Suven announces positive topline results from Phase-2 study of Samelisant for EDS in adult narcolepsy patients with and without cataplexy Read more
Top 20 global biopharma cos report marginal growth in market cap during Q3 2023: GlobalData Read more
SPARC completes enrolment in PROSEEK, Phase 2 study of Vodobatinib in early Parkinson’s disease Read more
Monoclonal antibodies for Nipah treatment to be developed indigenously: Kerala Health Minister Read more